BRPI0407991A - "composto, método para tratar um produto industrial com crescimento fúngico, composição, processo sintético para preparar a composição, e, métodos para controlar fungos e/ou bactérias, para tratar uma inflamação em um sujeito, para tratar uma infecção em um sujeito, para tratar um distúrbio auto-imune em um sujeito e para proteger uma planta de infecção fúngica, microcápsula,e, método para controlar insetos". - Google Patents

"composto, método para tratar um produto industrial com crescimento fúngico, composição, processo sintético para preparar a composição, e, métodos para controlar fungos e/ou bactérias, para tratar uma inflamação em um sujeito, para tratar uma infecção em um sujeito, para tratar um distúrbio auto-imune em um sujeito e para proteger uma planta de infecção fúngica, microcápsula,e, método para controlar insetos".

Info

Publication number
BRPI0407991A
BRPI0407991A BRPI0407991-4A BRPI0407991A BRPI0407991A BR PI0407991 A BRPI0407991 A BR PI0407991A BR PI0407991 A BRPI0407991 A BR PI0407991A BR PI0407991 A BRPI0407991 A BR PI0407991A
Authority
BR
Brazil
Prior art keywords
treating
subject
composition
infection
fungal
Prior art date
Application number
BRPI0407991-4A
Other languages
English (en)
Inventor
Richard B Klein
Jeffrey L Selph
John J Partridge
John F Reinhard
Original Assignee
Mycosol Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mycosol Inc filed Critical Mycosol Inc
Publication of BRPI0407991A publication Critical patent/BRPI0407991A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36—Radicals substituted by singly-bound nitrogen atoms
    • C07D213/38—Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Dermatology (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Otolaryngology (AREA)
  • Pain & Pain Management (AREA)
  • Ophthalmology & Optometry (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Pyridine Compounds (AREA)
  • Apparatus For Disinfection Or Sterilisation (AREA)

Abstract

"COMPOSTO, MéTODO PARA TRATAR UM PRODUTO INDUSTRIAL COM CRESCIMENTO FúNGICO, COMPOSIçãO, PROCESSO SINTéTICO PARA PREPARAR A COMPOSIçãO, E, MéTODOS PARA CONTROLAR FUNGOS E/OU BACTéRIAS, PARA TRATAR UMA INFLAMAçãO EM UM SUJEITO, PARA TRATAR UMA INFECçãO EM UM SUJEITO, PARA TRATAR UM DISTúRBIO AUTO-IMUNE EM UM SUJEITO E PARA PROTEGER UMA PLANTA DE INFECçãO FúNGICA, MICROCáPSULA, E, MéTODO PARA CONTROLAR INSETOS". Divulga-se compostos de sais de piridínio e métodos de sua utilização na medicina, particularmente na profilaxia e no tratamento de condições inflamatórias, condições infecciosas, e também distúrbios imunológicos. A presente invenção refere-se também a métodos de controlar fungos e/ou bactérias. Adicionalmente, a presente invenção refere-se a infestações fúngicas ou bacterianas relativas a usos industriais e agrícolas. A presente invenção também pode ser usada para controlar insetos.
BRPI0407991-4A 2003-03-03 2004-03-03 "composto, método para tratar um produto industrial com crescimento fúngico, composição, processo sintético para preparar a composição, e, métodos para controlar fungos e/ou bactérias, para tratar uma inflamação em um sujeito, para tratar uma infecção em um sujeito, para tratar um distúrbio auto-imune em um sujeito e para proteger uma planta de infecção fúngica, microcápsula,e, método para controlar insetos". BRPI0407991A (pt)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US45059903P 2003-03-03 2003-03-03
US48099503P 2003-06-23 2003-06-23
US52478403P 2003-11-25 2003-11-25
US52507503P 2003-11-25 2003-11-25
US52477503P 2003-11-25 2003-11-25
PCT/US2004/006437 WO2004078136A2 (en) 2003-03-03 2004-03-03 Pyridinium salts, compounds and methods of use

Publications (1)

Publication Number Publication Date
BRPI0407991A true BRPI0407991A (pt) 2006-03-07

Family

ID=32966824

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0407991-4A BRPI0407991A (pt) 2003-03-03 2004-03-03 "composto, método para tratar um produto industrial com crescimento fúngico, composição, processo sintético para preparar a composição, e, métodos para controlar fungos e/ou bactérias, para tratar uma inflamação em um sujeito, para tratar uma infecção em um sujeito, para tratar um distúrbio auto-imune em um sujeito e para proteger uma planta de infecção fúngica, microcápsula,e, método para controlar insetos".

Country Status (11)

Country Link
US (5) US7220761B2 (pt)
EP (1) EP1601652B1 (pt)
JP (1) JP4742028B2 (pt)
KR (1) KR20050108373A (pt)
AT (1) ATE402924T1 (pt)
AU (1) AU2004218452A1 (pt)
BR (1) BRPI0407991A (pt)
CA (1) CA2517461A1 (pt)
DE (1) DE602004015425D1 (pt)
MX (1) MXPA05009449A (pt)
WO (1) WO2004078136A2 (pt)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004078136A2 (en) * 2003-03-03 2004-09-16 Mycosol, Inc. Pyridinium salts, compounds and methods of use
SE527166C2 (sv) * 2003-08-21 2006-01-10 Kerttu Eriksson Förfarande och anordning för avfuktning
KR20070091653A (ko) * 2004-12-17 2007-09-11 마이코솔 인코포레이티드 티아졸륨 화합물 및 이의 용도
CN101128113B (zh) * 2005-02-24 2013-10-30 辛根塔参与股份公司 胶囊制剂
MX2007012486A (es) * 2005-04-08 2007-12-13 Mycosol Inc Ensayos de investigacion sobre estilbazio.
US20080295582A1 (en) * 2005-06-21 2008-12-04 Peng Lee Nondestructive Residential Inspection Method
US8247571B2 (en) 2005-11-08 2012-08-21 Mycosol, Inc. Pyridinium and thiazolium conjugates including polyethylene glycols and methods of using the same
WO2007056340A2 (en) * 2005-11-08 2007-05-18 Mycosol, Inc. Disinfectant and antiseptic pyridinium and thiazolium compounds and methods of using the same
US20070227399A1 (en) * 2006-04-03 2007-10-04 Novus International Inc. Compositions and methods for the preservation of wood
JP2007277790A (ja) * 2006-04-07 2007-10-25 Jae Woo Yang 熱色性物質層を備えたウォールペーパー及びその製造方法
WO2008088917A2 (en) * 2007-01-19 2008-07-24 Mycosol, Inc. Methods of using pyridinium and thiazolium compounds as reagents, diagnostic compounds and therapeutic agents
AU2009224813A1 (en) * 2008-03-10 2009-09-17 Basf Se Encapsulated phase change materials in seed coatings
US9538762B2 (en) * 2009-12-31 2017-01-10 Building Materials Investment Corporation Antimicrobial delivery system for roof coverings
US9642829B2 (en) * 2012-12-04 2017-05-09 The University Of Hong Kong Antifungal compound and uses thereof

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2790E (fr) * 1903-09-22 1904-06-15 David Perret Dispositif moteur électrique à double coupe-circuit
NL277327A (pt) 1961-04-24
US3085935A (en) * 1961-04-24 1963-04-16 Burroughs Wellcome Co Method for the elimination of nematode infestations
BE616609A (fr) * 1961-04-24 1962-10-18 Wellcome Found Composés ammonium quaternaires, procédé pour les préparer et compositions pharmaceutiques les contenant
GB1018454A (en) * 1962-10-18 1966-01-26 Smith Kline French Lab Improvements in or relating to antibacterial and antifungal compositions
ES297752A1 (es) * 1963-03-22 1964-08-16 Wellcome Found Un metodo para la preparaciën de una nueva sal de un catiën de diestilbazol cuaternario
DE1200302B (de) * 1963-04-30 1965-09-09 Bayer Ag Verfahren zur Herstellung von Monosalzen bisquartaerer Pyridiniumverbindungen
US3883658A (en) 1968-09-19 1975-05-13 Burroughs Wellcome Co Method of treating nematode infestations
US3867535A (en) 1971-12-01 1975-02-18 Ciba Geigy Corp Thiadiazolium salts as antihelmintic agents
US3934017A (en) 1971-12-07 1976-01-20 Ciba-Geigy Corporation Anthelmintic composition and method utilizing isothiocyanobenzazoles active ingredients
AR207744A1 (es) 1972-08-10 1976-10-29 Ciba Geigy Ag Procedimiento para la preparacion de nuevos derivados de isotiocianopiridinas
CA1022554A (en) * 1973-03-07 1977-12-13 Haukur Kristinsson 1-carbamoyl-2-alkoxycarbonylaminoimidazo (4,5-b) pyridines
DK645374A (pt) 1974-01-22 1975-09-29 Ciba Geigy Ag
US4105793A (en) * 1976-07-28 1978-08-08 Celanese Corporation Multifunctional acrylates as foliar fungicides
US4151298A (en) 1977-01-10 1979-04-24 Ciba-Geigy Corporation Anthelmintic compositions
NL7800192A (nl) 1977-01-10 1978-07-12 Ciba Geigy Als anthelmintica geschikte anilinomethyeenmalononi- trilederivaten.
US4205077A (en) * 1977-04-12 1980-05-27 Ciba-Geigy Corporation Benzimidazole sulphides as anthelmintic agents
US4197307A (en) 1977-04-12 1980-04-08 Ciba-Geigy Corporation 2-Alkylthio-, 2-alkylsulphinyl- and 2-alkylsulfonyl-6-phenylbenzimidazoles as anthelmintic agents
GB8323949D0 (en) 1983-09-07 1983-10-12 Wyeth John & Brother Ltd Pyridinium compounds
JP2941041B2 (ja) * 1990-11-16 1999-08-25 シスメックス株式会社 フローサイトメトリーによる白血球の分類方法
JP3070968B2 (ja) * 1991-05-14 2000-07-31 シスメックス株式会社 尿中の細胞分析用試薬及び方法
EP0759906A1 (en) 1995-03-20 1997-03-05 Orion Electric Co., Ltd. Stilbazolium salt, and preparation and use thereof
AU2001239544A1 (en) 2000-03-22 2001-10-03 Bf Research Institute, Inc. Image diagnosis probe based on substituted azobenzene or analogue thereof for disease attributable to amyloid accumulation and composition for image diagnosis containing the same
US20020044962A1 (en) * 2000-06-06 2002-04-18 Cherukuri S. Rao Encapsulation products for controlled or extended release
CA2439542A1 (en) * 2001-02-01 2002-08-08 Joshua S. Salafsky Designs of labels for detection with a surface-selective nonlinear optical technique
CN1394854A (zh) * 2002-07-04 2003-02-05 华东师范大学 多取代吡啶盐类化合物及其制备方法
WO2004078136A2 (en) * 2003-03-03 2004-09-16 Mycosol, Inc. Pyridinium salts, compounds and methods of use

Also Published As

Publication number Publication date
US20070213299A1 (en) 2007-09-13
CA2517461A1 (en) 2004-09-16
US20090137639A1 (en) 2009-05-28
AU2004218452A1 (en) 2004-09-16
JP2007525441A (ja) 2007-09-06
MXPA05009449A (es) 2006-04-07
DE602004015425D1 (de) 2008-09-11
KR20050108373A (ko) 2005-11-16
WO2004078136A2 (en) 2004-09-16
US20040224984A1 (en) 2004-11-11
EP1601652B1 (en) 2008-07-30
US20040235898A1 (en) 2004-11-25
US20100267716A1 (en) 2010-10-21
US7220761B2 (en) 2007-05-22
ATE402924T1 (de) 2008-08-15
EP1601652A2 (en) 2005-12-07
JP4742028B2 (ja) 2011-08-10
WO2004078136A3 (en) 2004-12-16
US7547444B1 (en) 2009-06-16
US7820696B2 (en) 2010-10-26
US8124626B2 (en) 2012-02-28

Similar Documents

Publication Publication Date Title
BRPI0407991A (pt) "composto, método para tratar um produto industrial com crescimento fúngico, composição, processo sintético para preparar a composição, e, métodos para controlar fungos e/ou bactérias, para tratar uma inflamação em um sujeito, para tratar uma infecção em um sujeito, para tratar um distúrbio auto-imune em um sujeito e para proteger uma planta de infecção fúngica, microcápsula,e, método para controlar insetos".
BR0107241A (pt) Compostos, processo de preparação dos compostos, uso dos compostos, composições fungicidas, processo de combate preventivo ou curativo dos fungos fitopatogênicos das culturas e método de tratamento preventivo ou curativo da madeira de construção
CR20240120A (es) Compuesto inductor de la degradación de PLK1 novedoso
EP4685213A3 (en) Purification of recycled and renewable organic material
PH12012501288A1 (en) Plant disease control composition and method for controlling plant diseases by applying the same
EP1719410A4 (en) METHOD FOR COMBATING PLANT HEALTH DAMAGE THROUGH THE USE OF BACILLUS AND A COMBUSTION AGENT
EA201101426A1 (ru) Способ подавления вредных грибов
BR0009430A (pt) Cepa do bacilo pumilus para controle de doenças de plantas
WO2003037259A3 (en) Methods for the prevention or treatment of bacterial and fungal infections
DE60012026D1 (de) Verwendung von emu-öl als träger für fungizide, antibakterielle und antivirale arzneien
BRPI0411501A (pt) composto, processos de preparação de composto, composição fungicida e método de combate preventivo ou curativo dos fungos fitopatogênicos
BR9713812A (pt) Controle biológico de infecções fúngicas de planta
BRPI0416720B8 (pt) composto, processo para a preparação de um composto, composição fungicida e método de combate curativo ou preventivo dos fungos fitopatogênicos de culturas
CY1110298T1 (el) Νεα μεθοδος για την παρασκευη παραγωγων βινυλ-πυρρολιδινο κεφαλοσπορινων
WO2007053581A3 (en) Growth control of oral and superficial microorganisms using gallium compounds
MX2023008775A (es) 5-fluoro-4-imino-3-metil-1-tosil-3,4-dihidropirimidin-2(1h)-ona para control de enfermedades de plantas.
WO2004037165A3 (en) Nitric oxide and its biomedical significance
PH12022550486B1 (en) Pathogenic control compositions and methods
WO2007074303A3 (fr) Protection des plantes contre leurs agents pathogenes
BRPI0417421A (pt) composto, composição farmacêutica, método para tratamento ou controle de infecções bacterianas, processo para preparação do composto e produto manufaturado
WO2022115510A9 (en) Antimicrobial peptides and method of preventing or treating infection by using the same
AP2001002165A0 (en) Use of phosphonoformic acid derivatives for treating infections
WO2010015913A3 (en) An agricultural composition, method for the production thereof and uses in the treatment of cultures
EP4197549A4 (en) COMPOSITION COMPRISING A MASS OF DEAD LACTIC ACID BACTERIA AS ACTIVE INGREDIENT FOR THE PREVENTION, RELIEF OR TREATMENT OF ALOPECIA OR PROSTATE HYPERTROPHY
DE602004011786D1 (de) Taurin bromamin für die inhibierung von pathogenen bakterien und pilzwachstum sowie in einer mikrobiziden zusammensetzung

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 6A, 7A E 8A ANUIDADE(S).

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: NAO APRESENTADA A GUIA DE CUMPRIMENTO DE EXIGENCIA. REFERENTE AS 6A, 7A E 8A ANUIDADES.